WASHINGTON--(BUSINESS WIRE/AETOSWire)-- Today, the U.S.-U.A.E. Business Council named Dr. Tomislav Mihaljevic, Chief Executive Officer and President of Cleveland Clinic, as Co- Chairman of its Board of Directors. Dr. Mihaljevic joins H.E. Waleed al Mokarrab Al Muhairi, Deputy Group CEO of Mubadala Investment Company, who serves as Co-Chairman of the Council.

In his current role as CEO and President, Dr. Mihaljevic leads the world-renowned Cleveland Clinic, a $10 billion healthcare system that includes a main campus in Cleveland, Ohio, 18 hospitals, more than 220 outpatient sites, and facilities in Florida, Nevada, Toronto, Abu Dhabi, and London.

“We are delighted that Dr. Mihaljevic is joining the Business Council as Co-Chairman of the Board of Directors,” said Danny Sebright, President of the U.S.-U.A.E. Business Council. Dr. Mihaljevic’s global experience will strengthen the Council’s ability to enhance the bilateral U.S.-U.A.E. economic and trade relationship, and provide greater value to our members.”

Dr. Mihaljevic praised Cleveland Clinic’s longstanding and fruitful relationship with the U.A.E. saying, “I could not be more honored to accept this new leadership role with the Business Council, and believe that it sets the stage for a new era of even closer cooperation with our close friends and partners in the U.A.E.”

Business Council Board of Directors Co-Chairman and Mubadala Deputy Group CEO, H.E. Waleed al Mokarrab Al Muhairi, heralded the appointment of Dr. Mihaljevic by saying, “The Business Council looks forward to the exciting contribution that Dr. Mihaljevic will make as the Board’s Co-Chairman, and I am confident that his appointment will further the Business Council’s efforts in advancing bilateral commercial relations between the U.S. and the U.A.E.”

Cleveland Clinic has a longstanding partnership with the U.A.E. and Dr. Mihaljevic previously served as CEO of Cleveland Clinic Abu Dhabi (CCAD), where he oversaw the 2015 opening of the 364-bed hospital and clinic, with 3,000 caregivers. The cutting-edge facility is transforming healthcare delivery in the region. Under his leadership, CCAD expanded its treatment capabilities, built relationships in the private and public sectors, and established its growing reputation for clinical excellence, research, and education. Under his leadership, Cleveland Clinic’s response to the Covid-19 pandemic has been exemplary, saving lives in both the United States and the U.A.E.

As co-Chairman of the Business Council, Dr. Mihaljevic will play a key role as the Business Council focuses on the healthcare sector. Over the last several years, promoting partnerships in the healthcare vertical has become a central pillar of the Business Council’s mission. This trend will only accelerate as a result of the Covid-19 pandemic. The U.S. and the U.A.E. will be key partners in 2021 in facilitating access to the Covid-19 vaccine throughout the Middle East, Africa, and South Asia.

The U.S.-U.A.E. Business Council is the premier business organization dedicated to advancing bilateral commercial relations. By leveraging its extensive networks in the U.S. and in the region, the U.S.-U.A.E. Business Council provides unparalleled access to senior decision makers in business and government with the aim of deepening bilateral trade and investment. For further information, please visit www.usuaebusiness.org or contact Ms. Mary Zuccarello at mzuccarello@usuaebusiness.org

View source version on businesswire.com: https://www.businesswire.com/news/home/20210125005804/en/ 

*Source: AETOSWire

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.